Ann Canterbury, MD
Cardiovascular Disease · Cincinnati, OHNPI 1902269533
Payments from drug & device makers
What this record shows
This record is dominated by grants: $27,522 of the $33,800 with a category attached, or 81.4%. 13 manufacturers reported payments, led by Abbott at 36.9% of the total. Reporting peaked in 2023 at $15,947 and has fallen 86.7% since, to $2,116 in 2025. Among cardiovascular disease clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 106 payments — averaging $318.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$12K
- Medtronic$12K
- Boston Scientific$8K
- Biosense Webster, Inc.$869
- Boehringer Ingelheim$55
- AstraZeneca$30
- plus $134 from 7 others
What the payments were for
- Grants$27,52281%
- Travel & lodging$1,9236%
- Food & beverage$4,02312%
- Education$3321%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 23 | $12,475 |
| Medtronic | 30 | $11,760 |
| Boston Scientific | 26 | $8,478 |
| Biosense Webster, Inc. | 16 | $869 |
| Boehringer Ingelheim | 3 | $55 |
| AstraZeneca | 1 | $30 |
| Edwards Lifesciences | 1 | $24 |
| Johnson & Johnson | 1 | $22 |
| Cardiva Medical, Inc. | 1 | $19 |
| Amgen | 1 | $19 |
| Novo Nordisk | 1 | $19 |
| Pfizer | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBLEM MRI S-ICD$3,750
- Micra$630
- ENSITE PRECISION$438
- AFFERA MAPPING SYSTEM$406
- Farapulse$290
- Carto 3$266
- AVEIR$215
- WATCHMAN Access System$123
How this compares
$33,800 in reported general payments places this provider in the 90th percentile of 827 cardiovascular disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 14 | $86 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Cincinnati
- Kamal ShemisaCincinnati$314K
- Richard BaeCincinnati$136K
- Dylan SteenCincinnati$91K
- Joel FormanCincinnati$64K
- Freidoon GhaziCincinnati$56K
- Wojciech MazurCincinnati$44K
- Guilherme AttizzaniCleveland$1.3M
- Gregory LamCircleville$428K
- Emil HayekHudson$379K
- Abraham LincoffCleveland$369K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.